Original ResearchPublished 9 October 2026Clinical challenges in vaccine and monoclonal antibody development against ESCAPE pathogens: insights from EMA scientific advice proceduresIgor Stojkov · Linda Marchioro · Isabelle Bekeredjian-Ding · Benjamin HofnerFrontiers in Medicinedoi 10.3389/fmed.2026.1931144
Original ResearchPublished 9 October 2026An experimentally validated manually curated genome-scale metabolic model of Enterococcus faecium TX0016 reproduces high-throughput phenotyping dataDina Samir Rasmi · Kalpathy Jayanth Krishnan · Yomna A. Hashem · Bernhard O. Palsson · Mona T. Kashef · Jonathan M. Monk · Ramy K. AzizFrontiers in Microbiologydoi 10.3389/fmicb.2026.1941652
Original ResearchPublished 7 August 2026Exploring the genomic landscape of antimicrobial resistance in XDR-ESKAPE pathogens: evidence-based implications for organism-targeted therapy in sepsisParkhi Shrivastava · Puneet Gandhi · Lalit Kumar · Anurag YadavaFrontiers in Disaster and Emergency Medicinedoi 10.3389/femer.2026.1884260
ReviewPublished 16 July 2026The molecular pathways of polyphenols in combating multidrug-resistant microbial superbugs: a comprehensive mechanistic reviewMichael T. Bayode · Shina Oguntuase · Joseph Chimezie · Ayomide Okiti · Esther Oyedeji · Isaac Ajayi · Jeremiah AdesanyaFrontiers in Natural Productsdoi 10.3389/fntpr.2026.1879559
Original ResearchPublished 13 July 2026Polyphenol-functionalized Fe 3 O 4 nanomaterials for combating multidrug-resistant ESKAPE pathogensLucian-Mihai Mercan · Andreea-Maria Pîndaru · Grațiela Grădişteanu Pircalabioru · Ilda Czobor Barbu · Elena-Carmina Drăgulescu · Melania Florina Munteanu · Elena Narcisa Pogurschi · Grigore MihăescuFrontiers in Nanotechnologydoi 10.3389/fnano.2026.1871019
Original ResearchPublished 29 June 2026ESKAPE pathogen alert: resistance trends in Pseudomonas aeruginosa from clinical isolates in Johannesburg (2019–2023)Sonalli Chaggan · Sumayya I. K. MietaFrontiers in Bacteriologydoi 10.3389/fbrio.2026.1869638
AntibioticsPublished 3 November 2025Susceptibility and resistance of Gram-negative bacteria to a novel antimicrobial agent TGV-49Victor V. Tetz · Kristina M. Kardava · Maria F. Vecherkovskaya · Semen A. Leyn · Marinela L. Elane · Andrei L. Osterman · George V. TetzFrontiers in Antibioticsdoi 10.3389/frabi.2025.1615821
